India is well positioned to emerge as a major market and a manufacturing hub for monoclonal antibodies
In alignment with the Biotechnology Policy and initiatives of the Gujarat State Biotechnology Mission, Dr. Sandeep Athalye shares his perspective on Kashiv’s journey to expand biomanufacturing capacity in India, in a conversation with Dr. Manbeena Chawla, Executive Editor, BioSpectrum.